Article

Membrane type-1 matrix metalloproteinase confers aneuploidy and tumorigenicity on mammary epithelial cells

Cancer Research Center, The Burnham Institute for Medical Research, La Jolla, California 92037, USA.
Cancer Research (Impact Factor: 9.28). 12/2006; 66(21):10460-5. DOI: 10.1158/0008-5472.CAN-06-2997
Source: PubMed

ABSTRACT An elevated expression of membrane type-1 matrix metalloproteinase (MT1-MMP) is closely associated with multiple malignancies. Recently, we discovered that recycled MT1-MMP was trafficked along the tubulin cytoskeleton into the centrosomal compartment and cleaved the integral centrosomal protein pericentrin-2. These events correlated with the induction of chromosome instability and aneuploidy in nonmalignant Madine-Darby canine kidney cells. Accordingly, we hypothesized that MT1-MMP is an oncogene that promotes malignant transformation of normal cells rather than just an enzyme that supports growth of preexisting tumors. To prove our hypothesis, we transfected normal 184B5 human mammary epithelial cells with MT1-MMP (184B5-MT1 cells). MT1-MMP was colocalized with pericentrin in the centrosomal compartment and especially in the midbody of dividing cells. 184B5-MT1 cells acquired the ability to activate MMP-2, to cleave pericentrin, and to invade the Matrigel matrix. 184B5-MT1 cells exhibited aneuploidy, and they were efficient in generating tumors in the orthotopic xenograft model in immunodeficient mice. Because of the absence of tumor angiogenesis and the resulting insufficient blood supply, the tumors then regressed with significant accompanying necrosis. Gene array studies confirmed a significant up-regulation of oncogenes and tumorigenic genes but not the angiogenesis-promoting genes in 184B5-MT1 cells. We believe that our data point to a novel function of MT1-MMP in the initial stages of malignant transformation and to new and hitherto unknown transition mechanism from normalcy to malignancy.

0 Followers
 · 
79 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The membrane PTK7 pseudokinase, a component of both the canonical and non-canonical/planar cell polarity Wnt pathways, modulates cell polarity and motility in biological processes as diverse as embryo development and cancer cell invasion. To determine the individual proteolytic events and biological significance of the ectodomain shedding in the PTK7 function, we used highly invasive fibrosarcoma HT1080 cells as a model system. Current evidence suggested a likely link between PTK7 shedding and cell invasion in our HT1080 cell model system. We also demonstrated that in HT1080 cells the cleavage of the PTK7 ectodomain by an ADAM proteinase was coupled with the membrane type-1 matrix metalloproteinase (MT1-MMP) cleavage of the PKP(621)↓LI site in the seventh Ig-like domain of PTK7. Proteolytic cleavages led to the generation of two soluble, N-terminal and of two matching C-terminal, cell-associated fragments of PTK7. This proteolysis was a prerequisite for the intramembrane cleavage of the C-terminal fragments of PTK7 by γ-secretase. γ-Secretase cleavage was predominantly followed by the efficient decay of the resulting C-terminal PTK7 fragment via the proteasome. In contrast, in HT1080 cells, which overexpressed the C-terminal PTK7 fragment, the latter readily entered the nucleus. Our data imply that therapeutic inhibition of PTK7 shedding may be used to slow cancer progression.
    Journal of Biological Chemistry 10/2012; DOI:10.1074/jbc.M112.371153 · 4.60 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinase-26 (MMP-26) is a novel member of the MMP family and plays a significant role in the progression of estrogen-dependent malignancies. The present study aimed to investigate the roles of MMP-26 in the growth, invasion and angiogenesis of breast cancer. pcDNA3.1(+)-neo expression plasmids carrying the proMMP-26 coding sequence were used to transfect a breast cancer cell line (MCF-7 cells). The mRNA and protein expression of MMP-26 was determined by RT-PCR, immunofluorescence analysis and flow cytometry. The morphology of transfected cells was observed under an electron microscope. An adherence and spreading assay, Boyden chamber assay, in vivo tumorigenicity assay and in vivo angiogenesis were further modeled to elucidate the roles of MMP-26 in the invasion and angiogenesis of breast cancer. Using electron microscopy, the MMP-26-transfected cells demonstrated increased atypia, including unusual mitotic figures, glucogen pools and special lysosomes in the cytoplasm. The adherence and spreading ability of MMP-26-transfected cells were increased significantly compared with cells in the control group. The Boyden chamber assay demonstrated that the migration and invasion ability of MMP-26-transfected cells was dramatically accelerated compared with the control group, but markedly reduced in the presence of anti-MMP-26 antibody. MMP-26 also increased the malignant phenotype in vivo. The number of vessel branches and the total length of vessels induced by MMP-26-transfected cells were significantly increased compared to those induced by non-transfected cells. The plasmid carrying the proMMP-26 gene was successfully transfected into breast cancer cells. Our results demonstrate that MMP-26 overexpression promotes the growth and invasion of breast cancer cells and induces angiogenesis.
    Oncology letters 10/2012; 4(4):832-836. DOI:10.3892/ol.2012.833 · 0.99 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The expression and implication of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) in residual hepatic tumor cells after lipiodol embolization were investigated. Two weeks after transplantation of VX2 tumor cells into the livers of rabbits, a xenograft model of the human hepatic neoplasm was successfully established. Forty rabbits were randomly divided into control group (n=20) and lipiodol group (n=20). For the control group, 1 mL normal saline was injected through the gastroduodenal artery, whereas 0.3 mL/kg lipiodol was applied for the lipiodol group. One week after embolization, the expression level of VEGF in the plasma was measured by using enzyme-linked immunosorbent assay (ELISA). A three-step immunohistochemical technique (ABC) was employed to detect the protein levels of VEGF and MMP-9 and the quantitative PCR for their mRNA levels was performed in the residual tumor cells. The VEGF in the plasma was significantly higher in the lipiodol group (1.42±0.29 ng/mL) than in the control group (1.12±0.21 ng/mL) (P<0.01). Moreover, the positive rate of VEGF protein in the residual tumor cells was significantly higher in the lipiodol group (62.13%±7.69%) than in the control group (53.16%±9.17%) (P<0.05). Similarly, the MMP-9 expression in the residual tumor cells was higher in the lipiodol group. The mRNA levels of VEGF (2.9313±2.4231) and MMP-9 (3.5721±1.6107) in the lipiodol group were significantly higher than those in the control group (1.5728±0.9453 and 1.7573±1.0641, respectively, P<0.05). Therefore, it was reasonable to speculate that the increased expression of VEGF and MMP-9 in residual hepatic tumor cells and tumor angiogenesis post-embolization would be responsible for the increased metastatic potentiality and invasiveness of these cells.
    Journal of Huazhong University of Science and Technology 02/2013; 33(1):90-5. DOI:10.1007/s11596-013-1077-z · 0.78 Impact Factor

Full-text (2 Sources)

Download
46 Downloads
Available from
Jun 1, 2014